NCT00247975 2022-08-16
Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
Ottawa Heart Institute Research Corporation
Phase 2/3 Terminated
Clinical Trials
3 trialsNCT04434404 2020-06-16
Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy
Horus University
Phase 4 Completed
NCT00754767 2017-09-11
L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer
HealthPartners Institute
Phase 4 Terminated